Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Protein Identification Platform To Be Installed in China

By Labmedica staff writers
Posted on 31 Jan 2008
A software platform for the identification and characterization of proteins and peptides from mass spectrometry (MS) data is to be installed in China.

Called Phenyx, the platform was specifically designed to meet the demands of high-throughput MS data analysis and dynamic results assessment while providing a flexible user experience and adaptable architecture to instill confidence in results assessment.

Geneva Bioinformatics (GeneBio; Geneva, Switzerland) SA and the Chinese State Key Laboratory of Proteomics (Beijing, China) have announced an agreement that GeneBio's Phenyx protein identification platform will be installed on the Chinese State Key Laboratory of Proteomics' High Performance Computing Cluster (32 nodes).

The director of the Chinese State Key Laboratory of Proteomics, Prof. More...
Fuchu He, is also co-chair of the Human Proteome Organization's Human Liver Proteome Project (HUPO HLPP). The license agreement is a further link between GeneBio and numerous HUPO projects, including the Proteomics Standards Initiative and the HUPO Brain Proteome Project.

"We are very pleased to be working with GeneBio and the SIB [Swiss Institute of Bioinformatics] and believe Phenyx to be the right platform for our cluster,” said Prof. Yunping Zhu of the Chinese State Key Laboratory of Proteomics. "Our laboratory is keen to provide the best results possible to our community, and for this it was obvious that the addition of Phenyx's capabilities was mandatory. The quality of the identification results together with the suite of features the software provides, amongst which features the possibility to compare results from all major search engines, were very important factors in our decision.”

The Phenyx platform can be used for clinical applications if a diagnostic test needs mass spectrometry applications and an MS/MS-based peptide and protein identification tool. Therefore, if the instrument is used in a product ion scan mode (MS/MS), it will be able to infer or validate the presence of a given diagnostic peptide.

Geneva Bioinformatics (GeneBio) SA is a bioinformatics company providing the life science community with proteomics software that bridges the gap between information gathering and knowledge generation. Its expertise is focused on protein identification and characterization as well as proteome imaging, offering clients and partners the high degree of specialization essential to proteomics research.

The Chinese State Key Laboratory of Proteomics focuses on the basic application and research of proteomics. It is the only state key laboratory in the field of proteomics in China. Scientific interests include the proteome and functional network of key tissue/organ of human, proteomics study of key diseases, systems biology based on proteomics, and novel techniques of proteomics.


Related Links:
Geneva Bioinformatics

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.